Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06142825 · ClinicalTrials.gov registry record · NA
Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya
A NA study of Blood Transfusion, sponsored by University of Minnesota.
- Active
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 1
- Study location
NCT06142825: Active NA study of Blood Transfusion, sponsored by University of Minnesota.
NCT06142825 is a NA study of Blood Transfusion that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 9 participants, below the 300-participant average among 3 other Blood Transfusion trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06142825, a NA study of Blood Transfusion, is active but no longer recruiting, sponsored by University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 1
- Study location
Study Summary
The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.
Primary Outcome
The proportion of transfusion requests resulting in dispatch of blood products from the laboratory
Conditions Studied
Interventions
- OTHER Community-Facility Transfusion Committee (CFTC)
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2025-03-11 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT06142825 still lists
NCT06142825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 300-participant average among 3 other Blood Transfusion trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Blood Transfusion appearing as the primary indexed condition, and to 1 intervention - of which Community-Facility Transfusion Committee (CFTC) is the first listed.
NCT06142825 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT06142825 about?
NCT06142825 is a clinical study titled "Developing, Implementing and Evaluating Effective Community-facility Interactions to Improve Blood Availability and Transfusion in Three Distinct County Settings in Kenya". The strategy of the CoBAnK study is to establish and enable the function of Community-Facility Transfusion Committees (CFTCs) incorporating diverse representation involving hospital, community, and county leadership, to improve blood availability and transfusion at the point-of-care.
What is the current status of trial NCT06142825?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2025-03-11. Estimated completion is 2026-07-01.
What conditions does trial NCT06142825 study?
This clinical trial studies the following conditions: Blood Transfusion.
What interventions are being tested in trial NCT06142825?
The interventions under investigation include: Community-Facility Transfusion Committee (CFTC) (OTHER).
Who is sponsoring clinical trial NCT06142825?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06142825 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Blood Transfusion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI